Administration of nitric oxide synthase inhibitors does not alter disease course of amyotrophic lateral sclerosis SOD1 mutant transgenic mice

Ann Neurol. 1999 Mar;45(3):413-4. doi: 10.1002/1531-8249(199903)45:3<413::aid-ana24>3.0.co;2-5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Animals
  • Mice
  • Nitric Oxide Synthase / administration & dosage*
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Superoxide Dismutase / genetics*
  • Superoxide Dismutase-1

Substances

  • Nitric Oxide Synthase
  • Sod1 protein, mouse
  • Superoxide Dismutase
  • Superoxide Dismutase-1